Multi Immunotherapy to Test Tolerance and Xolair
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Multi Immunotherapy to Test Tolerance and Xolair is a clinical trial[1].
Key Facts
- Multi Immunotherapy to Test Tolerance and Xolair is in the country of United States[2].
- Multi Immunotherapy to Test Tolerance and Xolair's instance of is recorded as clinical trial[3].
- Multi Immunotherapy to Test Tolerance and Xolair's start time is recorded as +2015-12-31T00:00:00Z[4].
- Multi Immunotherapy to Test Tolerance and Xolair's end time is recorded as +2016-11-16T00:00:00Z[5].
- Multi Immunotherapy to Test Tolerance and Xolair's contributor to the creative work or subject is recorded as University of Washington[6].
- Multi Immunotherapy to Test Tolerance and Xolair's main subject is recorded as food hypersensitivity[7].
- Multi Immunotherapy to Test Tolerance and Xolair's number of participants is recorded as {'unit': '1', 'amount': '+70'}[8].
- Multi Immunotherapy to Test Tolerance and Xolair's title is recorded as A Phase 2 Study Multi Oral Immunotherapy in Multi Food Allergic Patients to Test Tolerance M-TAX Study[9].
- Multi Immunotherapy to Test Tolerance and Xolair's short name is recorded as M-TAX[10].
- Multi Immunotherapy to Test Tolerance and Xolair's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+4'}[11].
- Multi Immunotherapy to Test Tolerance and Xolair's ClinicalTrials.gov ID is recorded as NCT02626611[12].
- Multi Immunotherapy to Test Tolerance and Xolair's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+55'}[13].
- Multi Immunotherapy to Test Tolerance and Xolair's research intervention is recorded as immunologic factor[14].
- Multi Immunotherapy to Test Tolerance and Xolair's clinical trial phase is recorded as phase II clinical trial[15].
- Multi Immunotherapy to Test Tolerance and Xolair's study type is recorded as interventional study[16].